STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.
Researchers found that sunburn disables a natural skin defense, allowing inflammation to trigger dangerous changes in cells. Understanding this process could help stop skin cancer before it starts.
CRISPR/Cas9 gene-editing therapy is a groundbreaking technology that enables highly precise modification of disease-causing ...
Abu Dhabi introduces a revolutionary gene therapy for hemoglobinopathies, utilizing CRISPR-Cas9 technology. Explore how this ...
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced, following approval at its 2025 Extraordinary General Shareholders' Meeting, that Foresee Pharmaceuticals USA Inc., the Company's ...
With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...
The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...
Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...
Zacks Investment Research on MSN

Three genomics stocks worth tracking this year

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...